Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...

Psychological and Sociocultural Causes of Schizophrenia

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

Biological Causes of Schizophrenia

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.

Schizophrenia

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Do cognitive and neurophysiological effects of acute memantine "challenge" predict its clinical benefits in Alzheimer's Disease?

Psychiatry research·2025

Same author

Pharmacologic Augmentation of Computerized Auditory Training in Chronic Psychosis: Preliminary Findings From a Single-Site, Double-Blind Study.

Schizophrenia bulletin·2025

Same author

Early auditory processing abnormalities alter individual learning trajectories and sensitivity to computerized cognitive training in schizophrenia.

Psychological medicine·2024

Same author

Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?

The American journal of psychiatry·2024

Same author

Amphetamine increases motivation of humans and mice as measured by breakpoint, but does not affect an Electroencephalographic biomarker.

Cognitive, affective & behavioral neuroscience·2024

Same author

Prepulse inhibition and the call alert in emergency medical services.

Psychophysiology·2024

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Are we studying and treating schizophrenia correctly?

Neal R Swerdlow¹

¹School of Medicine, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0804, United States. nswerdlow@ucsd.edu

Schizophrenia Research

|June 8, 2011

Summary

Schizophrenia involves brain circuit dysfunction due to maturation failures. A new treatment model integrates rehabilitative psychotherapy with targeted medications to improve cognitive function and manage symptoms.

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Related Experiment Videos

Last Updated: Jun 1, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

Area of Science:

Neuroscience
Psychiatry
Genetics

Background:

Schizophrenia is characterized by neural and molecular dysfunctions within cortico-striato-pallido-thalamic circuits.
These disturbances may stem from impaired early brain development, leading to altered cell development and connectivity.
Variability in circuit disturbances suggests interactions between genetic and epigenetic factors.

Purpose of the Study:

To propose a novel, practical treatment strategy for schizophrenia.
To integrate emerging findings on neural circuit dysfunction into actionable therapeutic models.
To shift focus from prevailing genetic/molecular models to a rehabilitative approach.

Main Methods:

A three-part treatment strategy is proposed.
1) Rehabilitative psychotherapies to engage healthy neural systems.
2) Medications targeting cognitive mechanisms, and 3) Antipsychotics for limbic-motor circuit points.

Main Results:

The proposed strategy aims to compensate for and replace dysfunctional circuit elements.
Medications are suggested to synergize with cognitive rehabilitation.
This approach seeks to constrain psychotic exacerbations and facilitate engagement in therapy.

Conclusions:

Effective schizophrenia treatment requires a divergence from traditional genetic and molecular neuroscience models.
A practical, three-part strategy combining psychotherapy and targeted medications offers a promising therapeutic direction.
This integrated approach shows potential for treating schizophrenia, drawing parallels with other neuropsychiatric disorders.